Dr. Zarrinpar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 SW Archer Rd Dept of
Gainesville, FL 32610Phone+1 352-265-0761
Summary
- Dr. Ali Zarrinpar is a General Surgeon in Gainesville, FL, specializing in Hepatobiliary Surgery, Surgical Oncology (non-breast), and Transplantation. He completed his residency in Surgery and a fellowship in Transplant Hepatology at UCLA David Geffen School of Medicine/UCLA Medical Center following his graduation from the University of California San Francisco School of Medicine in 2005. Since 2017, he has been an Attending Surgeon at the University of Florida College of Medicine, after serving as an Attending Physician and Assistant Professor at the David Geffen School of Medicine at UCLA from 2012 to 2017. Dr. Zarrinpar has experience in non-alcoholic fatty liver disease, transplant hepatology, hepatocellular carcinoma, and transplant surgery. His recent publications cover diverse topics, including immune checkpoint inhibitors post-transplant, patient outcomes in cancer surgery, and effects of immunosuppression variability in liver transplantation. Additionally, he is involved in clinical trials focusing on imaging for biliary tract and tumor identification and optimizing immunosuppression drug dosing.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Transplant Hepatology, 2010 - 2012
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Surgery, 2005 - 2010
- University of California San Francisco School of MedicineClass of 2005
Certifications & Licensure
- FL State Medical License 2017 - 2027
- CA State Medical License 2006 - 2026
- American Board of Surgery Surgery
Clinical Trials
- A Pilot Dosing and Timing Study to Optimize Imaging When Utilizing Endoscopic Fluorescence Imaging System During Laparoscopic Biliary and Hepatic Operations Start of enrollment: 2014 Jan 01
- Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine Start of enrollment: 2018 Sep 21
- Low Dose ICG for Biliary Tract and Tumor Imaging Start of enrollment: 2021 Sep 15
Publications & Presentations
PubMed
- Outcomes of Coronary Artery Bypass Grafting for Asymptomatic Patients Referred for Renal Transplant.Enoch J Wong, Connor M McDonald, Elizabeth Thomas, Ali Zarrinpar, Lawrence Lee
Clinical Transplantation. 2025-03-01 - Immune checkpoint inhibitors in the posttransplant landscape of HCC: A systematic literature review.Doga Kahramangil, Ali Zarrinpar, Ilyas Sahin
Liver Transplantation. 2024-12-16 - Patient Outcomes in Resected Combined Hepatocellular Cholangiocarcinoma (cHCC-ICC) and Intrahepatic Cholangiocarcinoma: A Single Center Study.Rick Y Lin, Doga Kahramangil, Muhammet Ozer, Thomas J George, Ibrahim Nassour
Cancers. 2024-11-20
Press Mentions
- Study Highlights Racial Disparities in Liver Transplantation ListingJanuary 11th, 2021
- College Researchers Probe Racial Disparity in Fatty Liver DiseaseApril 11th, 2019
- Demographic Factors Increasing Risk of Liver Cancer Development in Patients with Fatty Liver DiseaseMarch 20th, 2019
- Join now to see all
Professional Memberships
- Member
- Fellow
- Member
- Member
- American Society of Transplant SurgeonsMember
- American Society of TransplantationFellow
- Society of University SurgeonsMember
- Americas Hepato-Pancreato-Biliary AssociationMember
- American Association for the Study of Liver DiseasesMember
- International Liver Transplant SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: